Australia's largest stock trading and investment forum Australia's #1 stock forum

CE1

Click for more information

0.00%

0.9¢ calima energy limited

Ann: March 2023 Quarterly Activities and Cash Flow Report, page-54

First 54 Last

Share
Profile

Follow
Access2020

1,802 Posts.

1911

23/05/23

12:50

Post #: 67915679
Share

Originally posted by BerserkWarrior: ↑

So Directors shower themselves with performance shares and related party payments whilst the company trades at lows. Tell me how that's an equitable relationship between management & shareholders? I'm voting against Freeman in particular as a Director when his term comes up again. I'd implore others to do so as well- it might make the other Directors wake up & start treating shareholders as the people they work for rather than those that fund their lifestyle. For the life of me I have no idea what Freeman brings as a 'Finance Director' when we have a full time CFO.

Time and gain I see companies with good assets/potential projects that don't get traction due to management ineptitude in being able to execute a business plan both on budget & importantly to a timeline. Enough of teflon tonsiled smooth talking presentations. Just deliver

Expand

Totally agree mate. Freeman is a light weight. A CFO and finance director for this company is overkill.

But at least Mark has been buying shares. Glen did a while back but not seeing any other management/ director buying.

CE1 Price at posting: 9.5¢ Sentiment: None Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BUX

Buxton projects new graphite province discovery at WA Narryer play

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 4 more messages in this thread...

First 54 Last

Add CE1 (ASX) to my watchlist